2004Zhonghua fangshexian yixue zazhiRequires access

Preliminary research on multi-slice helical CT perfusion and MR perfusion in soft tissue tumors

Ning Dian-xi

Open publisher page 1 citations

Abstract

Objective To assess the diagnostic value of MSCT and MR perfusion in the differentiation of benign and malignant soft tissue tumors.Methods Twenty-six patients with soft tissue tumors were studied in MSCT perfusion and 29 patients in MR perfusion. The differences of perfusion parameters of benign and malignant tumors were analyzed.Results The average value of MSCT BF was (24.49±14.49) ml·100mg -1·min -1 for malignant group, and (1.98±1.19) ml·100mg -1·min -1 for benign group. PS was (14.64±1.89) ml·100 mg -1·min -1 for malignant group, and (2.40±0.38) ml·100 mg -1·min -1 for benign group. The mean BF and PS in benign and malignant tumors had significant difference in MSCT perfusion. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of MSCT in estimating the potential malignancy of the tumors were 90.9% (10/11), 86.7%(13/15), 88.5%(23/26), 83.3% (10/12), and 92.9% (13/14), respectively. The average value of MR BF was (0.11±0.02) ml·100mg -1·min -1 for malignant group, and (0.07±0.01) ml·100mg -1·min -1 for benign group. The mean BF in benign and malignant tumors has significant difference in MR perfusion. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of MR in estimating the potential malignancy of the tumors were 91.7% (11/12), 88.2% (15/17), 89.7% (26/29), 84.6%(11/13), and 93.8% (15/16), respectively.Conclusion MSCT and MR perfusion are very helpful in the differentiation of benign soft tissue tumors from malignant ones.

About this research paper

What this paper is about

Objective To assess the diagnostic value of MSCT and MR perfusion in the differentiation of benign and malignant soft tissue tumors.Methods Twenty-six patients with soft tissue tumors were studied in MSCT perfusion and 29 patients in MR perfusion. The differences of perfusion parameters of benign and malignant tumors were analyzed.Results The average value of MSCT BF was (24.49±14.49) ml·100mg -1·min -1 for malignant group, and (1.98±1.19) ml·100mg -1·min -1 for benign group. PS was (14.64±1.89) ml·100 mg -1·min -1 for malignant group, and (2.40±0.38) ml·100 mg -1·min -1 for benign group. The mean BF and PS in benign and malignant tumors had significant difference in MSCT perfusion. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of MSCT in estimating the potential malignancy of the tumors were 90.9% (10/11), 86.7%(13/15), 88.5%(23/26), 83.3% (10/12), and 92.9% (13/14), respectively. The average value of MR BF was (0.11±0.02) ml·100mg -1·min -1 for malignant group, and (0.07±0.01) ml·100mg -1·min -1 for benign group. The mean BF in benign and malignant tumors has significant difference in MR perfusion. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of MR in estimating the potential malignancy of the tumors were 91.7% (11/12), 88.2% (15/17), 89.7% (26/29), 84.6%(11/13), and 93.8% (15/16), respectively.Conclusion MSCT and MR perfusion are very helpful in the differentiation of benign soft tissue tumors from malignant ones.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To assess the diagnostic value of MSCT and MR perfusion in the differentiation of benign and malignant soft tissue tumors.Methods Twenty-six patients with soft tissue tumors were studied in MSCT perfusion and 29 patients in MR perfusion. The differences of perfusion parameters of benign and malignant tumors were analyzed.Results The average value of MSCT BF was (24.49±14.49) ml·100mg -1·min -1 for malignant group, and (1.98±1.19) ml·100mg -1·min -1 for benign group. PS was (14.64±1.89) ml·100 mg -1·min -1 for malignant group, and (2.40±0.38) ml·100 mg -1·min -1 for benign group. The mean BF and PS in benign and malignant tumors had significant difference in MSCT perfusion. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of MSCT in estimating the potential malignancy of the tumors were 90.9% (10/11), 86.7%(13/15), 88.5%(23/26), 83.3% (10/12), and 92.9% (13/14), respectively. The average value of MR BF was (0.11±0.02) ml·100mg -1·min -1 for malignant group, and (0.07±0.01) ml·100mg -1·min -1 for benign group. The mean BF in benign and malignant tumors has significant difference in MR perfusion. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of MR in estimating the potential malignancy of the tumors were 91.7% (11/12), 88.2% (15/17), 89.7% (26/29), 84.6%(11/13), and 93.8% (15/16), respectively.Conclusion MSCT and MR perfusion are very helpful in the differentiation of benign soft tissue tumors from malignant ones.

Key concepts: Medicine, Perfusion, Malignancy, Nuclear medicine, Soft tissue, Perfusion scanning, Predictive value, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
Preliminary research on multi-slice helical CT perfusion and MR perfusion in soft tissue tumors — Research Paper | ScholarLens